The team, led by CBI research scientist Donovan Guttieres published ‘Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2’ in the March 2021 volume of Antibody Therapeutics.
This work was funded by the MIT-IBM Watson AI Lab and was previously featured in MIT news.